Table 3.
PD (20 lesions/4 patients) | Non-PD (52 lesions/12 patients) | P value for PD vs non-PD | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Median change | Optimal cut-off (ROC curve analysis) | Number of lesions identified (↑ or ↓) | Number of patients identified (↑ or ↓) | Median change | Number of lesions identified (↑ or ↓) | Number of patients identified (↑ or ↓) | |||||||
Value | AUC | Opt cut-off | 25 % cut-off | Opt cut-off | 25 % cut-off | Opt cut-off | 25 % cut-off | Opt cut-off | 25 % cut-off | ||||
SUVmax (%) | − 2.2 | − 20.6 | 0.76 | 18 ↑ | 2 ↑ | 4 ↑ | 0 ↑ | − 27.2 | 33 ↓ | 52 ↓ | 7 ↓ | 12 ↓ | 0.001 |
SUVmean (%) | 0.4 | − 21.7 | 0.77 | 18 ↑ | 1 ↑ | 4 ↑ | 0 ↑ | − 24.2 | 28 ↓ | 52 ↓ | 4 ↓ | 12 ↓ | 0.001 |
SUVpeak (%) | 0.6 | − 15.0 | 0.76 | 17 ↑ | 2 ↑ | 3 ↑ | 0 ↑ | − 24.7 | 33 ↓ | 52 ↓ | 6 ↓ | 12 ↓ | 0.001 |
MTV (%) | 10.7 | − 14.1 | 0.70 | 17 ↑ | 4 ↑ | − 19.7 | 30 ↓ | 6 ↓ | 0.006 | ||||
TLM (%) | 4.2 | − 24.1 | 0.76 | 18 ↑ | 4 ↑ | − 40.2 | 33 ↓ | 6 ↓ | 0.001 | ||||
SD (%) | 4.1 | − 23.4 | 0.72 | 16 ↑ | 4 ↑ | − 33.5 | 33 ↓ | 7 ↓ | 0.004 | ||||
Ent (%) | − 0.7 | − 2.2 | 0.55 | 15 ↑ | 4 ↑ | − 1.1 | 33 ↑ | 7 ↑ | 0.458 | ||||
Unif (%) | 2.8 | 5.8 | 0.59 | 15 ↓ | 3 ↓ | 4.4 | 27 ↓ | 6 ↓ | 0.235 | ||||
Kurt (abs) | 0.1 | 0.2 | 0.51 | 16 ↓ | 4 ↓ | 0.09 | 29 ↓ | 7 ↓ | 0.826 | ||||
Skew (abs) | 0.05 | − 0.13 | 0.55 | 14 ↑ | 0 | 4 ↑ | 0 | − 0.03 | 29 ↑ | 6 ↑ | 0.517 |
MTV metabolic tumour volume, TLM tumour lesion metabolism, SD standard deviation, Ent entropy, Unif uniformity, Kurt kurtosis, Skew skewness, abs absolute change, % percentage change, ↑ ≥ the cut-off value, ↓ < the cut-off value